Todd Thomson - Director, 16.4% Owner at Actuate Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director, 16.4% Owner
Stock Symbol
ACTU on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Todd Thomson since 10/6/2023

Holdings reported by Todd Thomson for Actuate Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 1.18M $6.24M $5.27 Aug 14, 2024 By KVP II, L.P.
Common Stock 873K $4.6M $5.27 Aug 14, 2024 By KVOI, L.P.
Common Stock 322K $1.7M $5.27 Aug 14, 2024 By Kairos SPV Fund, LLC
Common Stock 255K $1.34M $5.27 Aug 14, 2024 By Kairos-Actuate SPV, L.P.
Non-Qualified Stock Options 15K Aug 12, 2024 Direct Common Stock
Series B-1 Redeemable Convertible Preferred Stock 0 Aug 14, 2024 By KVP II, L.P. Common Stock
Series B-2 Redeemable Convertible Preferred Stock 0 Aug 14, 2024 By KVOI, L.P. Common Stock
Series B-3 Redeemable Convertible Preferred Stock 0 Aug 14, 2024 By Kairos SPV Fund, LLC Common Stock
Series B-3 Redeemable Convertible Preferred Stock 0 Aug 14, 2024 By KVOI, L.P. Common Stock
Series B-3 Redeemable Convertible Preferred Stock 0 Aug 14, 2024 By KVP II, L.P. Common Stock
Series B-4 Redeemable Convertible Preferred Stock 0 Aug 14, 2024 By Kairos-Actuate SPV, L.P. Common Stock
Series B-4 Redeemable Convertible Preferred Stock 0 Aug 14, 2024 By Kairos SPV Fund, LLC Common Stock
Series C Redeemable Convertible Preferred Stock 0 Aug 14, 2024 By Kairos-Actuate SPV, L.P. Common Stock
Series C Redeemable Convertible Preferred Stock 0 Aug 14, 2024 By Kairos SPV Fund, LLC Common Stock
Warrant (Right to Buy) 0 Aug 14, 2024 By KVP II, L.P. Common Stock

Transactions reported by Todd Thomson for Actuate Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.